Mensinger Mike 4
4 · Beta Bionics, Inc. · Filed Jan 7, 2026
Insider Transaction Report
Form 4
Mensinger Mike
Chief Product Officer
Transactions
- Sale
Common Stock
2026-01-06$30.10/sh−2,200$66,221→ 80,752 total
Footnotes (2)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025.
- [F2]The weighted average sale price for the transaction reported was $30.1005 and the range of prices were between $30.00 and $30.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.